✨ Free AI Report
Regen BioPharma Inc: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Regen BioPharma Inc
Research Preview

Regen BioPharma Inc: Business Overview, Financials & Competitive Analysis

Regen BioPharma is a microcap biotechnology company focused on immunology, immunotherapy, and regenerative approaches to hematological and oncologic conditions, emphasizing autologous cell therapies, RNA and DNA-based...

Analyst-debate audio for Regen BioPharma Inc

AskCyborg analysts argue the bull and bear cases for Regen BioPharma Inc across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Regen BioPharma Inc OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
2/ 10Challenged

Cyborg Score thesis

Pre-revenue microcap biotech with severe liquidity crisis and heavy equity dilution; investment-grade risk management is...

Read the full analyst-debate transcript →
Industry Biotechnology - Cell Therapy & Immunotherapy
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: June 22, 2026
AI-Verified Research
30+ Page Report

Get the Latest Regen BioPharma Inc Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Regen BioPharma Inc Overview

Pro stress-test →

Regen BioPharma is a microcap biotechnology company focused on immunology, immunotherapy, and regenerative approaches to hematological and oncologic conditions, emphasizing autologous cell therapies, RNA and DNA-based therapeutics, and small molecules in immune-oncology. The company was incorporated in 2012 and is based in La Mesa, California.

Strategic Profile

Pro stress-test →

The company is transitioning HemaXellerate and related programs from preclinical development into human clinical trials. The product pipeline includes HemaXellarate (autologous stromal vascular fraction from adipose tissue), dCellVax (autologous dendritic cell therapy), tCellVax, DiffronC, and DuroCAR (CAR-T cells).

Competitive Landscape

Pro stress-test →

Within the broader biotechnology sector, Regen BioPharma positions itself as a microcap company focused on immunology, immunotherapy, and regenerative approaches. Direct competitors include larger, well-funded CAR-T and dendritic cell therapy developers (e.g., Juno Therapeutics, Deneon Therapeutics). Regen BioPharma's competitive disadvantage is acute: minimal revenue, no approved products, and critical liquidity constraints.

Industry Context

Regen BioPharma Inc operates in Biotechnology - Cell Therapy & Immunotherapy.

Key facts

Founded: 2012 · Headquarters: La Mesa, CA, US · Employees: Not disclosed · Revenue: $237K (TTM); $118K (H1 2026) · Market cap: $127.4K

What the analysts stress-tested

The top findings that survived the multi-agent debate for Regen BioPharma Inc.

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Regen BioPharma Inc has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Juno Therapeutics CAR-TCAR-T cell immunotherapy for oncology→Deneon TherapeuticsDendritic cell-based immunotherapy→Fate TherapeuticsOff-the-shelf cell therapy for oncology→

Compare Regen BioPharma Inc with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Regen BioPharma Inc operates in Biotechnology - Cell Therapy & Immunotherapy. See how the rest of the sector scores on the Cyborg framework.

Browse Biotechnology - Cell Therapy & Immunotherapy research →
NEW · MCP server

Ask your AI assistant about Regen BioPharma Inc

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Regen BioPharma Inc and its top competitor on Cyborg Score”
“What did Regen BioPharma Inc do this quarter?”
“Is Regen BioPharma Inc a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Regen BioPharma Inc do?+
Regen BioPharma is a microcap biotechnology company focused on immunology, immunotherapy, and regenerative approaches to hematological and oncologic conditions, emphasizing autologous cell therapies, RNA and DNA-based...
What is Regen BioPharma Inc's Cyborg Score?+
Regen BioPharma Inc has a Cyborg Score of 2/10 (Challenged). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Regen BioPharma Inc's main competitors?+
Named competitors include Juno Therapeutics CAR-T, Deneon Therapeutics, Fate Therapeutics. The full competitive landscape is in the AskCyborg report.
How can I get the full Regen BioPharma Inc research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Regen BioPharma Inc research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Regen BioPharma Inc over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

Other strong performers across the analyst-debate framework. Click any to see their research report.

9Sezzle Inc.9Carpenter Technology Corporation9Credo Technology Group Holding Ltd9TE Connectivity plc9Rheinmetall AG9Northrop Grumman Corporation9Interactive Brokers Group, Inc.9Berkshire Hathaway Inc.9Mastercard Incorporated8Vera Therapeutics, Inc.8Quoin Pharmaceuticals, Ltd.8Prenetics Global Limited8Strattec Security Corporation8Lesaka Technologies Inc.8Abu Dhabi Ship Building PJSC8Judges Scientific plc8Weathernews Inc.8Orrstown Financial Services, Inc.